Stay updated on FGF401 in HCC and Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the FGF401 in HCC and Solid Tumors Clinical Trial page.

Latest updates to the FGF401 in HCC and Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedPage layout and navigation appear updated; no core study data (eligibility criteria, endpoints, locations, or results) is visibly changed.SummaryDifference0.0%

- Check13 days agoChange DetectedThe page now displays Revision: v3.4.2, replacing Revision: v3.4.1.SummaryDifference0.0%

- Check20 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1. This appears to be a minor update to the page's backend or formatting and does not change study details or content.SummaryDifference0.0%

- Check27 days agoChange DetectedAdded a Show glossary toggle and updated minor footer text (Last Update Submitted that Met QC Criteria; No FEAR Act Data) and changed the Revision from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No study content or critical information was changed.SummaryDifference0.0%

- Check63 days agoChange DetectedThe Locations section was updated to include new site regions (California, Massachusetts, Texas, Shanghai Municipality, Ille Et Vilaine, MI, MO, Osaka, Tokyo, Catalonia) and the previous location subsections were removed. A revision tag was added as v3.3.3.SummaryDifference0.9%

Stay in the know with updates to FGF401 in HCC and Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FGF401 in HCC and Solid Tumors Clinical Trial page.